PDL BioPharma (PDLI) Misses Q3 EPS by 19c
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Interest and other expense: -4.51M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Interest and other expense: -4.51M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q3 EPS of $0.42, $0.19 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $124.6 million versus the consensus estimate of $164.8 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
- NextNRG, Inc. (NXXT) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
